Skip to content

Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section

Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section: a Randomized Trial. (TAP-CAT Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03102515
Acronym
TAP-CAT
Enrollment
109
Registered
2017-04-05
Start date
2016-05-29
Completion date
2016-10-26
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Analgesia following surgery associates different intra-venous or oral analgesic drugs and sometimes opioids. To reduce opioid consumption, loco-regional anaesthesia might be administered as a complement. In the specific context of caesarean sections, pain control is mandatory to enable the mother to take care of her offspring and shorten their hospital stay. This intervention is mainly performed under neuraxial anaesthesia (spinal or epidural), enabling the injection of morphine in the subdural or epidural space, as part of a multimodal analgesia regimen. Studies have evaluated continuous wound infiltration catheters (CIC) and ultrasound-guided (UGD) transabdominis plane (TAP) block, and both techniques and both techniques reduce postoperative morphine consumption. Recent studies have compared the two techniques and found conflicting results. Furthermore, they did not consider caesarean section performed under epidural analgesia, with a different neuraxial injection site, neither did they compared pain after postoperative day 2. Consequently, the aim of this study was to compare resting and standing pain up to postoperative day 3 after caesarean section performed under spinal or epidural anaesthesia and receiving either USG-TAP block or CIC. Baseline hypothesis was that the continuous infiltration provided a better analgesia at day 2.

Interventions

DRUGUSG-TAP block
DRUGCIC

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent, * Age\>/=18 years, * Caesarean section under spinal or epidural anaesthesia * Technique surgical Cohen Stark méthod.

Exclusion criteria

* Patient refusal, * Patient under guardianship, * Contraindication to one of the two techniques, * Cesarean section under general anesthesia * Allergies to local anesthetics * Maternal instability

Design outcomes

Primary

MeasureTime frameDescription
Postoperative standing pain at day 2Evaluate standing pain at 48 hours postoperativelyAssessment of Pain on Mobilization by a Numeric Scale of Pain

Secondary

MeasureTime frameDescription
standing and resting pain measured during the first 3 daysEvaluate pain at during 3 days postoperativelyAssessment of Pain by a Numeric Scale of Pain
Cumulative dose of Tramadol during the first 3 daysduring the first 3 days
Cumulative dose of nefopam during the first 3 daysduring the first 3 days
Cumulative dose of oxycodone during the first 3 daysduring the first 3 days
patient comfort assessed daily by visual analogic scaleduring the first 3 daysby visual analogic scale

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026